Marios Fotiadis is an investor specializing in private equity globally, with investments completed in North and South America, Europe and the Middle East representing over 1 billion USD in committed capital. Marios started his career in investment banking with SG Cowen in New York. He then moved to SG Capital Partners in 1998, where he began his career in private equity. At SG Capital, Marios focused on investments in growth and venture capital with an emphasis in healthcare and technology companies. Marios then became the CEO of Achillion Pharmaceuticals Inc (NASDAQ “ACHN”) where he completed a successful turnaround that culminated with an IPO on NASDAQ. From Achillion, Marios moved to Advent International based in Boston where he was a partner with a focus on global investments in health care and life sciences. Following Advent, Marios became the Managing Partner of TVM Capital MENA, where he raised the first private equity fund in the MENA region dedicated to investments in health care and pharmaceuticals.
Since 2012, Marios has been responsible for managing the investment office of his family. The main activity of the investment office is sourcing, closing and managing direct investments in private equity as well as doing asset allocation and overseeing the selection of managers for the public side of the portfolio. The existing private equity portfolio includes 8 direct investments in the Americas, Europe and the Middle East. Marios Holds a BSBA degree cum laude from University of Denver and an MBA from Columbia University in New York.
Next, read about Mireille Gillings, Ph.D.